Company intelligence / Profile preview

GT Medical Technologies

Tempe, Arizona, United Statesgtmedtech.com ↗

Ownership: Private
Employees: ~55
Development stage: Commercial

Overview

GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy for patients with operable brain tumors. Clinical data demonstrate positive local control and safety outcomes for large brain metastases and high-grade gliomas. Ongoing clinical trials include ROADS for newly diagnosed brain metastases and GESTALT for newly diagnosed glioblastomas. The product is commercially available at over 100 centers across the US[3][7][8].

Therapeutic areas: Oncology
Modalities: DeviceRadiopharmaceuticalBioresorbable implant therapy
Industry: Implantable Medical Devices

Drug pipeline

1 asset

GammaTile

Commercial

Indications: Brain tumors, Brain metastases, Glioblastoma

Partnerships

Isoray, Inc.

Beyond the preview

Go deeper on GT Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GT Medical Technologies.

Explore the full profile